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Abstract
Retrospective studies and surveillance on humans and animals revealed that Rift Valley Fever virus (RVFV) has been
circulating on Mayotte for at least several years. A study was conducted in 2011 to estimate the seroprevalence of RVF in
humans and in animals and to identify associated risk factors. Using a multistage cluster sampling method, 1420 individuals
were enrolled in the human study, including 337 children aged 5 to 14 years. For the animal study, 198 seronegative
ruminants from 33 randomly selected sentinel ruminant herds were followed up for more than one year. In both studies,
information on environment and risk factors was collected through a standardized questionnaire. The overall weighted
seroprevalence of RVFV antibodies in the general population aged $5 years was 3.5% (95% CI 2.6–4.8). The overall
seroprevalence of RVFV antibodies in the ruminant population was 25.3% (95% CI 19.8–32.2). Age ($15), gender (men),
place of birth on the Comoros, living in Mayotte since less than 5 years, low educational level, farming and living close to a
water source were significantly associated with RVFV seropositivity in humans. Major risk factors for RFV infection in animals
were the proximity of the farm to a water point, previous two-month rainfall and absence of abortions disposal. Although
resulting in few clinical cases in humans and in animals, RVFV has been circulating actively on the island of Mayotte, in a
context of regular import of the virus from nearby countries through illegal animal movements, the presence of susceptible
animals and a favorable environment for mosquito vectors to maintain virus transmission locally. Humans and animals share
the same ways of RVFV transmission, with mosquitoes playing an important role. The studies emphasize the need for a one
health approach in which humans and animals within their ecosystems are included.
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Introduction
Rift Valley Fever (RVF) is a mosquito-borne zoonosis that
affects domestic animals and humans [1]. The RVF virus (RVFV)
was first detected in Kenya [2] but later spread on the African
continent and Yemen [1]. Among important RVF epizootics and
epidemics reported, many occurred in East-African countries,
geographically close to Mayotte. In 2006–2007, a large outbreak
spread from Kenya to Tanzania [3] and Madagascar [4].
Humans are infected by RVFV through contact with blood or
organs of infected animals, during slaughtering or when handling
infected animals and contaminated meat. Transmission of the
virus also results of bites from mosquitoes and possibly other
bloodsucking vectors [1].
Following the identification of the first human case of RVF
on Mayotte, imported from the Comoros Islands in 2007,
retrospective studies were conducted on humans and animals
and prospective surveillance set up [5–7]. Results revealed that
RVF virus has been circulating on the island for at least several
years, even before the detection of the first human case, without
leading to detectable clinical cases in neither animals nor humans.
A study was conducted in 2011 to estimate the seroprevalence of
Rift Valley Fever in the general population and in animals
(ruminant population) in Mayotte, as well as to identify factors
associated with human and animal RVF infection on the island.
Materials and Methods
Setting, design and population
Mayotte is a French overseas department located in the Indian
Ocean, between the Eastern African coast and Madagascar. The
island is very densely populated and has around 200,000
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inhabitants of whom 53% are under 20 years of age, on a surface
of 374 km2 [8]. Forty per cent of the population are foreigners,
most of them illegal immigrants coming from the Comoros. Given
the proximity of Mayotte and the Comoros, both part of the
Comoros archipelago, travel (legal and illegal movements) between
the islands is frequent. General hygiene and living conditions on
Mayotte are poor.
The human serosurvey used a multistage cluster sampling
method. First, 60 small geographical units (districts) were
randomly selected among a total of 783, with proportionate
probability to their size. In each district, a number of households
were randomly selected to participate to the study, until inclusion
of at least 24 individuals per district. Finally, in each household
three persons were invited to participate by simple random
sampling, including one child aged 5 to 14 years and two adults
($15 years). If only 1 child and/or 2 adults were living in the
house, all individuals were invited to participate. Up to two
additional house visits were made at different times of the day and
week to allow inclusion of absent members or households. The
study objects were enrolled over a five week-period in March
2011, in accordance with written informed consent procedures.
For the animal study, only ruminant herds were included.
Thirty-three sentinel ruminant herds were randomly chosen in
different environments and followed up for more than one year,
from March 2010 to August 2011; only seronegative ruminants
(more than 10 months old for bovines and 6 month-old for small
ruminants) at the first visit were included in the follow up
(Figure 1). These 198 ruminants (131 bovines and 67 small
ruminants; 14 sheep and 53 goats) were blood-sampled each
month and each clinical case was reported and further analysed.
All the ruminants of these herds (452 adults and young; 378 cattle,
14 sheep and 60 goats) were blood-sampled during the last visit in
July 2011.
Data collection
After enrolment of human participants and blood sampling by a
nurse, a questionnaire was administered to each individual to
collect socio-demographic data (gender, age, place of birth,
schooling, travel history), exposition to potential risk factors
(occupation, presence of mosquitoes, contact with animals or
blood and organs) as well as protective measures taken. A second
questionnaire was administered to the head of the family with
questions on housing conditions including composition of the
household, building materials and equipment of the house and
presence of animals.
For animals, a questionnaire was systematically submitted to
cattle owners at the first visit. Information related to the farm
characteristics and practices (number of animals, age, housing,
feeding…) and the local environment (vegetation type, minimum
distance from the farm to the nearest water point, type of the
nearest water point, minimum distance from the farm to the
nearest forest boundary…) was collected.
Laboratory methods
The laboratory measure of RVFV exposure in humans was
seroconversion, indicated by serum specific IgG RVFV antibodies
as marker of past infection, using an in-house indirect ELISA test
prepared by the National Reference Centre for Arboviruses
(NRC-Arbo) in 2011 at the Institut Pasteur. The NRC-Arbo
confirmed the seropositivity of tested samples using in-house MAC
and GAG ELISA tests for the capture of human RVFV IgM or
IgG, respectively.
The animal serums were analysed using commercial ELISA kits
to detect IgG RVFV antibodies (BDSL or IdVet (innovative
diagnostics VET, ID ScreenH Rift Valley fever Competition Multi-
species ELISA)).
Statistical analysis
Statistical analysis was used to describe the distribution of
RVFV-specific IgG positivity among the sampled population
(humans and animals). Odds ratios (OR) and their 95%
confidence intervals were calculated for exposure factors. For
humans, crude prevalence estimations and OR were adjusted
according to the inclusion probability of each individual and
further weighted by post-stratification for age and gender
distribution in the general population (2007 population census).
A backwards approach (logistic regression) was used to construct a
multivariate model which included risk factors with significance
level of #0.20 in the univariate analysis. P values ,0.05 were
considered statistically significant. Weighted results only are
presented. For analysis in animals, the contribution of each factor
to the model was tested with a likelihood-ratio x2 through a
stepwise procedure (backward and forward). At the same time, the
simpler models were compared to the full model by the Akaike
information criterion [9]. This process was continued automati-
cally until a model was obtained with all factors significant at
P,0.05 (two-sided). Goodness-of-fit of the final model was assessed
using Pearson x2 and Deviance tests [10].
We used EPIDATA 3.0 software (Epidata Association, Odense,
Denmark) for double data entry and STATA 11.0 (Statcorp.
College Station, TX, USA) for statistical analysis.
Ethics statement
Participation in the human survey was proposed on a voluntary
basis. After oral information of participants in the local languages
(French, Shimaore, Shibushi), written consent was obtained from
adults or guardians of children ,18 years prior to the inclusion.
For illiterate participants, verbal consent was obtained after lecture
of the informed consent letter, with signature of the consent form
by an adult family member. All data were collected anonymously.
Laboratory results were linked to the questionnaires based on a
unique code. The study protocol, including informed consent
procedure, was approved by the French competent authorities and
ethical committee, in compliance with all French regulations on
protection of human subjects (Commission nationale de l9in-
formatique et des liberte´s (CNIL), nu 910467; Comite´ de
protection des personnes Sud-Ouest et Outre-Mer III (CPP), nu
2010-A00593-36).
Although not compulsory, the study protocol on animals was
approved by the ethical committee of Cyroi (Cyclotron Re´union
Oce´an Indien), a technical platform for bio-science in Reunion
Island, France. The permission for inclusion of the herds in the
study was obtained from each owner on the site. Blood samples
were obtained from jugular vein without suffering and were
collected in sterile VacutainerH.
Results
Characteristics of participants and seroprevalence in
humans
A total of 60 districts, distributed over 43 villages geographically
spread on the island of Mayotte were sampled. Out of the 910
households randomly selected to participate, 729 (80%) were
enrolled in the study; for 10.5% of households, inhabitants were
absent and 9.5% refused participation. The total number of
individuals enrolled was 1420, of whom 337 (23.7%) were children
aged 5 to 14 years. Refusal of participation of individuals within
participating households was higher for children (18%) than for
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adults (6%). The main reason for refusal was the fear of needles.
The mean number of households and individuals included in each
district was 13 (range 8–20) and 24 (range 18–26) respectively.
Participants were aged 5 to 90 years, with a mean age of 31 for
men and 32 for women. Compared to the whole population (2007
Census), women were over-represented (61.7% versus 51%), as is
usually observed in epidemiological studies. Despite inclusion of
one child per household, children aged 5 to 14 years were under-
represented (23.8% versus 32.8%). Crude data were therefore
weighted for age and gender.
Of the 1413 sera that could be analysed, 58 (4.1%) were positive
for RVFV IgG. The overall weighted seroprevalence of RVFV
antibodies in the general population aged $5 years was 3.5%
(95% CI 2.6–4.8). The age specific seroprevalence of RVF was
very low in children 5–14 years old and was highest in the age
group of 15 to 34 years, with a decrease in older age groups
(Table 1). No significant difference was observed according to
gender and geographical area. The highest seroprevalence rates
were observed in farmers (32.1%) and persons with animal
birthing activity or in contact with aborted animal fetuses (27.8%).
Seroprevalence and incidence in animals
A total of 33 farms (198 ruminants), spread on the island of
Mayotte, have been regularly sampled (Figure 1). The overall
seroprevalence of RVFV antibodies in the ruminant population
was 25.3% (95% CI 19.8–32.2) in August 2011 but 61.9% of the
farms (95% CI 44.8–79.2) were positive. No significant difference
was observed between small ruminants (22.4%–5% CI 14.1–32.2)
Figure 1. Geographical distribution of ruminant herds included in the study and overall seroprevalence of RVFV IgG antibodies in
the ruminant population, Mayotte, 2011.
doi:10.1371/journal.pone.0074192.g001
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and cattle (26.8%–5% CI 19.1–35.3). The animal incidence from
the 1st quarter 2010 to the 3rd quarter 2011 was 12.9% (95% CI
9.6–16.2) with a peak of 18.8% for the 4th quarter 2010, during
the rainy season.
Analysis of risk factors for humans
In univariate statistical analyses, RVFV seropositivity varied
significantly according to the following factors: age ($15 years of
age), place of birth (higher risk for people born on the Comoros),
duration of residence in Mayotte (increased risk if ,5 years), low
educational level, professional activity (higher risk for farmers and
unemployed people), assist with animal birthing or disposal of
aborted animal fetuses, and living close to a water source (river,
swamp, water draining system…) (Table 1). Gender, environment,
activities of slaughtering, cooking fresh meat, handling dead
animals, and consumption of raw milk or fresh blood were not
significantly associated with an increased risk of RVF in univariate
analysis (Table 1). Other studied factors that did not significantly
influence RVF seroprevalence were: history of regular travel to
countries where outbreaks of RVF occurred, protection against
mosquitoes and housing conditions (access to piped water, type
and size of the house and number of inhabitants) (data not shown).
Table 1. Adjusted prevalence of RVFV IgG antibodies in the general population $5 years and Odds ratios in univariate analysis
according to demographic variables and potential risk factors, Mayotte, 2011.
Variable Subcategory
Tested individuals
(N)
Adjusted prevalence
% (95% CI) Adjusted OR (95% CI) p
Gender Male 542 4.3 (2.7–7.0) 1
Female 871 3.0 (2.1–4.3) 0.69 (0.39–1.23) 0.20
Age (years) 5–14 335 0.4 (0.8–1.7) 1
15–34 495 5.4 (3.7–8.0) 15.21 (2.97–77.78) 0.001
35–54 410 4.6 (2.5–8.1) 12.70 (2.51–64.16) 0.003
$55 168 2.8 (1.1–6.7) 7.70 (1.60–36.80) 0.01
Birthplace Mayotte 806 1.4 (0.6–3.0) 1
Comoros 528 7.7 (5.5–10.8) 6.10 (2.43–15.37) 0.000
Other 63 0 -
Residence in Mayotte ,5 years 155 10.0 (5.1–18.8) 1
$5 years 1248 2.9 (2.0–4.1) 2.78 (1.37–5.34) 0.001
Educational level Primary school or less 817 4.5 (3.2–6.4) 1
College up to university 588 1.8 (1.0–3.3) 0.37 (0.17–0.71) 0.002
Geographical area North 215 3.2 (1.4–6.9) 1
Center 261 4.1 (3.0–5.4) 1.29 (0.54–3.08) 0.56
Mamoudzou capital town 478 3.0 (1.7–5.3) 0.96 (0.35–2.62) 0.93
Petite Terre 172 2.2 (0.8–5.6) 0.68 (0.19–2.45) 0.55
South 287 4.9 (2.3–10.1) 1.57 (0.51–4.87) 0.43
Occupation Administrative 761 1.3 (0.7–2.4) 1
Farmer 19 32.1 (13.4–59.0) 35.21 (9.36–132.35) 0.000
Unemployed 633 5.5 (3.9–7.7) 4.34 (2.20–8.55) 0.000
Slaughtering No 1289 3.3 (2.3–4.5) 1
Yes 124 6.7 (2.8–15.1) 2.15 (0.81–5.70) 0.12
Birthing or abortion No 1405 3.3 (2.5–4.5) 1
Yes 8 27.8 (3.8–78.8) 11.12 (1.10–112.3) 0.04
Handling dead animals No 870 3.3 (2.1–5.1) 1
Yes 543 3.8 (2.4–6.1) 1.16 (0.57–2.35) 0.68
Cooking fresh meat No 730 3.0 (1.9–4.7) 1
Yes 386 4.2 (2.8–6.1) 1.41 (0.77–2.55) 0.26
Raw milk consumption No 885 3.8 (2.5–5.7) 1
Yes 528 3.2 (1.9–5.3) 0.88 (0.45–1.72) 0.70
Fresh blood consumption No 1408 3.5 (2.6–4.8) 1
Yes 5 0 0 (0–18.12) 0.93
Environment Urban 751 2.9 (1.7–4.7) 1
Rural 661 4.2 (2.8–6.2) 1.47 (0.74–2.93) 0.65
Nearby water source No 628 2.0 (1.1–3.6) 1
Yes 784 4.8 (3.3–7.0) 2.46 (1.17–5.16) 0.02
doi:10.1371/journal.pone.0074192.t001
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Multivariate analysis identified the following factors to be
significantly associated with RVFV seropositivity: age ($15),
gender (men), place of birth on the Comoros, living in Mayotte
since less than 5 years, low educational level, farming and living
close to a water source (Table 2).
Analysis of risk factors for ruminants
In univariate statistical analysis, significant risk factors for
RVFV seropositivity were: new animals introduced in the herd
(lent from other farms), selling of animals, no use of insecticides on
cattle or deworming treatment (with albendazole), farm located
nearby a water point (#1000 m), no constant access to a water
point, no immediate disposal of aborted fetuses, and heavy rainfall
(.180 mm) in the previous 2 months (Table 3). Animal feeding
conditions, keeping cattle in the farm with or without small
ruminants, a daily route for cattle in the forest, fighting against
rodents, presence of ticks, type of vegetation in which ruminants
are grazing or potential contact with other ruminants were not
significantly associated with an increased risk of RVF in univariate
analysis (data not shown).
Multivariate analysis identified only 3 major risk factors to be
significantly associated with RVFV seropositivity: location of the
farm nearby a water point, heavy rainfall in the previous
two months and absence of abortions disposal (Table 4).
Discussion
The seroprevalence of Rift Valley Fever virus IgG antibodies in
the general population aged 5 years or more in Mayotte estimated
by this first large scaled study was 3.5%, with the highest
prevalence observed in the 15 to 34 years old (5.4%). Because in-
house indirect ELISA has been used for the detection of RVF
antibodies in tested sera, all dubious and positive biological
samples were subsequently validated by Mac and Gag ELISA tests
with a high degree of confidence. Such serological methods were
particularly suitable for limiting the risk of a biased estimate of the
prevalence rate. During outbreaks, prevalence rates up to 32%
have been registered [11], but interepidemic seropositivity in
different contexts and countries varied between 3% in Tanzania,
13% in Kenya and 22% in Senegal [12–14]. In a rural population
in Gabon, a country where like Mayotte, no outbreaks of RVF
have ever been reported, seroprevalence was estimated at 3.3%
[15].
The seroprevalence of Rift Valley Fever virus IgG antibodies in
ruminants older than ten months, estimated by this follow up was
25.3%, much higher than the one observed in humans. These
results are in accordance with those from previous studies in
Mayotte conducted from 2004 to 2007, where prevalence rates
between 12 and 32% were registered [6]. They are also similar
with observations from the other islands in the Indian Ocean, in
Comoros [16] and in Madagascar [17], where the seroprevalence
rates were 32.8% in 2009 and 25.6% in 2008, respectively. These
data were obtained from livestock during inter-epizootic periods,
but the rates observed are close to those reported during or close
after epizootics, for example in Kenya [18] or in Mauritania [19],
where prevalence rates from 12% to 33% were registered.
However seroprevalence results in animal studies need to be
balanced regarding the composition of herds. Indeed, goats are
highly susceptible to infection, even if they appear to be more
refractory to severe or lethal disease than sheep and cattle. Several
studies revealed that approximately 2% to 10% of goats are
seropositive for anti–RVF virus antibody during enzootic periods
but this percentage rose up to 70% following epizootics [20,21]. In
our study, we sampled bovines and small ruminants, mainly goats.
However, no significant difference of prevalence was observed
between cattle and small ruminants. The incidence rate obtained
from the follow up of animal herds was 12.9%, much higher than
the ones observed in Senegal (5.4%) in small ruminants or in
Kenya (4.9%) in livestock [21,18].
Both the studies in humans and in animals indicate that the
RVFV has been circulating actively on the territory of Mayotte,
since at least 2004. Several arguments tend to indicate that the
virus is probably imported from nearby Comoros islands, affected
by RVF because of regular imports of live ruminants from eastern
Africa, mainly Tanzania [16]. The human cases of RVF
diagnosed in Mayotte in 2007 and 2008 were genetically linked
to the Kenyan outbreak of 2006–2007, that also affected the
Comoros [22]. In our study, people born in the Comoros or those
recently living in Mayotte (,5 years) are at greater risk of RFV
infection than people born in Mayotte (see further). And high
seropositivity rates (37%) have been observed among animals
illegally imported from the Comoros islands (Anjouan mainly) and
tested at their arrival, suggesting that illegal animal movements are
a likely source of RVFV introduction in Mayotte [6].
However, seroprevalence rates obtained in animals from 2004
to 2011 and the high incidence rate in 2010–2011 in ruminants
strongly support the evidence of maintenance of the virus
circulation in Mayotte, in addition to regular import. A peak of
18.8% incidence was observed in 2010 during the rainy season, a
favorable period for mosquitoes to multiply. During periods with
less-excessive rainfalls, RVF virus is likely maintained in an
enzootic cycle within the mosquito vector population, involving
transovarial transmission with occasional infection and amplifica-
tion of virus in susceptible cattle or small ruminants [23]. Several
mosquito species that have been identified as possible vector for
RVF are present in Mayotte, including Ae. circumluteolus, Cx.anten-
natus, Cx. quinquefasciatus and Ae. Aegypti [6,24]. In 2009, the virus
was found (by PCR) on a Ae. simpsonii mosquito [25]. And a recent
inventory of mosquitos captured around the animal herds included
Table 2. Final logistic regression model presenting
significantly associated risk factors for RVF in the general
population $5 years, Mayotte, 2011.
Variable Subcategory
Adjusted OR
(95% CI) p
Gender Male 2.33 (1.19–4.55) 0.01
Female* 1
Age 5–14* 1
$15 6.17 (1.11–34.29) 0.04
Birthplace Mayotte/other* 1
Comoros 3.28 (1.43–7.45) 0.006
Residence in Mayotte ,5 years 2.96 (1.39–6.31) 0.006
$5 years* 1
Educational level Primary school or
less
2.34 (1.04–5.23) 0.04
College up to
university*
1
Occupation Administrative* 1
Farmer 9.24 (1.50–56.81) 0.02
Nearby water source No* 1
Yes 2.24 (1.03–4.88) 0.04
*reference category.
doi:10.1371/journal.pone.0074192.t002
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in our study described 40 mosquito species belonging to 9 genera,
including all the competent species for RVFV transmission [26]
suggesting that the virus could be easily transmitted to livestock by
these insects.
Age $15 years has been identified as a possible risk factor for
RVF seropositivity in humans. However, the low seroprevalence
in children 5 to 14 years old is probably related to behaviour
Table 3. Adjusted prevalence of RVFV IgG antibodies in the ruminant population and Odds ratios in univariate analysis according
to potential risk factors, Mayotte, 2011.
Variable Subcategory
Tested individuals
(N)
Adjusted prevalence
% (95% CI)
Adjusted OR
(95% CI) p
Type of production Milk and meat 253 33.6 (29.1–38.1) 1
Milk or meat 169 35.5 (30.9–40.1) 1.10 (0.75–1.65) 0.59
Selling of animals No 52 17.3 (13.7–20.9) 1
Yes 370 36.7 (32.1–41.3) 2.70 (1.29–5.72) 0.008
Buying of animals No 260 34.2 (29.6–38.8) 1
Yes 162 34.5 (29.9–39.1) 1.11 (0.67–1.52) 0.95
Reception of lent animals* No 148 26.3 (22.1–30.5) 1
Yes 274 38.6 (34.0–43.2) 1.79 (1.16–2.78) 0.009
Lending of animals No 381 34.1 (29.6–38.6) 1
Yes 41 36.5 (31.9–41.1) 1.13 (0.56–2.13) 0.78
Management of dead animals Good process 157 33.6 (29.1–38.1) 1
Bad process 265 35.5 (30.9–40.1) 1.10 (0.66–1.35) 0.6
Management of dead fetuses* Eliminated 223 30.0 (25.6–34.4) 1
Kept into the farm 199 39.1 (34.5–43.7) 1.47 (1.13–2.17) 0.04
Use of insecticides* Yes 210 27.1 (22.9–31.3) 1
No 212 41.5 (36.9–46.1) 1.82 (1.30–2.86) 0.005
Use of acaricides Yes 360 33.8 (29.3–38.3) 1
No 62 37.0 (32.4–41.6) 1.10 (0.67–1.16) 0.75
Deworming* Yes 98 26.5 (22.3–30.7) 1
No 324 36.7 (32.1–41.3) 1.65 (1.15–2.63) 0.04
Nearby water point* No 208 22.5 (18.5–26.5) 1
Yes 214 45.8 (41.0–50.6) 1.55 (1.13–2.12) 0.007
Constant access to water point* Yes 98 26.5 (22.5–30.5) 1
No 324 36.7 (31.2–41.3) 1.62 (1.13–2.12) 0.04
Distance to the water point* .1000m 202 28.2 (24.2–32.2) 1
#1000m 220 40.1 (35.4–44.8) 1.72 (1.15–2.56) 0.01
Previous two month rainfalls* #180mm 227 25.1 (21.1–29.1) 1
.180mm 195 45.1 (40.3–49.9) 2.56 (1.67–3.85) 0.0001
*variable retained after univariate analysis for the logistic model.
doi:10.1371/journal.pone.0074192.t003
Table 4. Final logistic regression model presenting significantly associated risk factors for RVF in the ruminant population,
Mayotte, 2011.
Variable Subcategory Adjusted OR (95% CI) p
Nearby water point No* 1
Yes (permanent or not) 1.55 (1.13–2.12) 0.04
Previous two month rainfalls #180mm* 1
.180mm 2.22 (1.45–3.45) 0.003
Management of dead fetuses Eliminated 1
Kept into the farm* 1.82 (1.12–2.94) 0.01
*reference category.
doi:10.1371/journal.pone.0074192.t004
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factors and less cumulative exposition to mosquitoes and does not
indicate that the virus circulated more on the island 15 years ago.
As found in other studies [13,15], men living in Mayotte were
three times more exposed to RVFV than women. A possible
reason is that men spend more time outside the house and are thus
more exposed to mosquito bites.
The highest association to RVFV seropositivity (in univariate
analysis only, small number) was found with assisting animals
during birth or abortions (OR of 27.8), also described in Senegal
and Kenya [13,14]. Slaughtering, cooking fresh meat, contact with
dead animals and drinking raw milk were not significantly
associated with RVF infection.
In our study, people with a low educational level (no schooling
or primary level only) were at greater risk for RVFV infection than
those with a higher level.
The higher exposure of people born in the Comoros and recently
living in Mayotte (,5 years) suggest that RVFV circulation was
more important in the other islands of the Comoros archipelago
than in Mayotte. However, Comorian people might have been
more exposed to the virus after their arrival on Mayotte than local
people, through occupational activities such as farming, found to be
a main risk factor for RVFV infection (OR 9.2). Indeed, farms often
belong to Mahorais people but daily work is carried out by
immigrants. Travelling to the Comoros islands is not significantly
associated to a higher RVFV seropositivity.
Proximity to a water source, identified as a risk factor in
Mayotte was also described in Tanzania, Gabon and Saudi Arabia
[12,15,27]. Although protection against mosquito bites did not
significantly influence on RVFV seropositivity, it seems that
mosquitoes and other bloodsucking vectors play an important role
in RVFV transmission on the island.
As for humans, a main risk factor associated with animal RVFV
seropositivity was the presence of a nearby water point from the
farm or the night-pen for ruminants animal, confirming that a
substantial part of the virus transmission in Mayotte could be
carried out by mosquito vectors. Most of the mosquito species
identified as potential vectors for RFV in Mayotte [26],
particularly Culex and Aedes genera, have a main crepuscular
and nocturnal activity [28], and given that cattle come back to the
farm in the afternoon, a great distance between animals and the
water point limits the risk to be bitten by mosquitoes and then the
risk to be infected. The abundance of the rainfalls is a crucial
factor for the setting of mosquitoes breeding sites and low rainfall
(less than 180 mm per month) especially during the rainy season
was associated with a lower animal seropositivity. Indeed,
persistent rainfall creates non-permanent water points, resulting
in new breeding sites for mosquitoes.
Another risk factor for ruminants associated with a higher
seropositivity was non-disposal of aborted fetuses. A systematic
elimination of dead fetuses after abortions (dead fetuses could be
buried, burnt or consumed) reduced the direct risk of virus
transmission; as for humans, ruminants can become infected
through contacts with blood, tissues, secretions or excretions of
infected animals, notably after abortion [29]. Aborted fetal
materials and placental membranes contain large numbers of
virus particles which can either contaminate the local environment
directly or infect animals in close contact. The RVFV may persist
for relatively long periods in the environment as it has been
demonstrated during in vitro experiments [30].
Although the human and animal serosurveys suggest significant
circulation of RVFV on the island, very few human clinical cases
have been detected and few abortions or mortality among young
ruminants reported, despite active and passive surveillance.
Infection in humans is often asymptomatic and clinical signs,
when present, are non-specific for RVF. However, in 2010 and
2011, more than 1400 PCR-tests for RVFV were performed in
Mayotte, on people presenting with fever and dengue-like illness.
All were negative. The absence of clinical cases in animals might
be explained by a sufficiently high density of susceptible animals
on the island to sustain virus circulation but not high enough to
support waves of epidemic abortion and death [6]. Before any
launching of epizootics, multiple infected mosquito bites are
required to generate a high level of viremia in animals and only
when considerable number of ruminants are heavily infected,
amplification could take place through direct transmission of the
virus with infected tissues and propagation with blood-sucking
insects [23]. During these inter-epizootic periods, viremia in
ruminants remain low resulting in few infected mosquitoes and an
absence of symptomatic cases in animals and humans. Alterna-
tively, the RVFV virus may persist in an unidentified vertebrate
reservoir [31], but our first studies carried out in 2011 on 100 rats
and 50 lemurs, potential wild reservoirs of the virus, revealed no
presence of specific antibodies (unpublished data).
Conclusions
Although resulting in few clinical cases in humans and in animals,
RVFV has been circulating actively on the island of Mayotte since
several years, in a context of regular import of the virus from nearby
countries through illegal animal movements, the presence of
sufficient numbers of susceptible animals and a favorable environ-
ment for mosquito vectors to maintain virus transmission locally.
Several risk factors highlighted that humans and animals share
the same ways of RVFV transmission. Non disposal of an aborted
animal fetus as risk factor may indicate the importance of virus
transmission by aerosolization of blood and amniotic fluid during
animal birthing. Exposure to infected tissues and body fluids
remains the main route of infection for humans but is also at risk
for ruminants [32]. Proximity to a water source confirmed that
abundant mosquito breeding places and then abundant mosquito
population could facilitate transmission to ruminants and to
humans [1].
Finally, farming and cattle ownership are important factors for
RVFV seropositivity; such a result was expected since ruminants
are the main animal host of RVFV.
Our studies emphasize the need for a one health approach in
which humans and animals within their ecosystems are included.
Only these holistic approaches that acknowledge the interdepen-
dence of people, domestic and wild animals, and the environment
will better address today’s dynamic health threats and propose
adequate control measures to limit these threats.
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